Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2020 Sep 25;216:108323. doi: 10.1016/j.drugalcdep.2020.108323

Table 1:

Visit characteristics for emergency department visits estimating any and only amphetamine-type stimulantsa and comparing only amphetamine-type stimulants to all other drug overdosesb, 2017

Any amphetamine-type stimulant overdose Only amphetamine-type stimulant overdose Drug overdose not including amphetamine-type stimulants Unadjusted PRc (95%CI) Adjusted PRc (95%CI)
Visit characteristic n (%) 95% CI of % n (%) 95% CI of % n (%) 95% CI of %
All 42,428 27,226 929,040
Sex
 Male 27,316 (64.4) (63.0–65.9) 18,336 (67.4) (65.6–69.2) 444,219 (47.8) (47.0–48.6) 1.41 (1.37–1.45) d
 Female 15,092 (35.6) (34.1–37.1) 8,871 (32.6) (30.8–34.4) 484,715 (52.2) (51.4–53.0) 0.63 (0.59–0.66) d
Age group
 ≤ 24 9,880 (23.3) (21.4–25.4) 6,534 (24.0) (21.7–26.3) 279,025 (30.0) (28.9–31.2) 0.80 (0.73–0.88) d
 25–34 13,208 (31.1) (29.8–32.5) 8,037 (29.5) (27.9–31.1) 190,630 (20.5) (19.8–21.2) 1.44 (1.36–1.53) d
 35–54 14,859 (35.0) (33.7–36.4) 9,715 (35.7) (34.0–37.4) 255,267 (27.5) (26.8–28.1) 1.30 (1.24–1.36) d
 ≥ 55 4,482 (10.6) (9.2–11.9) 2,939 (10.8) (9.0–12.6) 204,117 (22.0) (21.3–22.6) 0.49 (0.42–0.58) d
Census regione
 Northeast 2,499 (5.9) (4.8–7.0) 1,467 (5.4) (4.3–6.4) 161,810 (17.4) (15.0–19.8) 0.31 (0.26–0.37) 0.34 (0.29–0.40)
 Midwest 8,726 (20.6) (17.0–24.1) 5,066 (18.6) (15.2–22.0) 242,262 (26.1) (23.4–28.7) 0.71 (0.61–0.83) 0.74 (0.65–0.85)
 South 14,988 (35.3) (30.7–40.0) 9,097 (33.4) (28.5–38.3) 344,513 (37.1) (33.9–40.2) 0.90 (0.79–1.03) 0.94 (0.84–1.06)
 West 16,215 (38.2) (32.5–43.9) 11,596 (42.6) (36.0–49.2) 180,454 (19.4) (17.6–21.3) 2.19 (1.89–2.54) 2.02 (1.78–2.30)
County urbanization levelf
 Large central metro 13,143 (32.5) (27.6–37.5) 8,821 (34.2) (28.5–39.9) 272,442 (29.6) (26.5–32.7) 1.15 (0.99–1.34) 1.05 (0.92–1.20)
 Large fringe metro 6,240 (15.4) (12.8–18.1) 3,736 (14.5) (11.7–17.3) 193,880 (21.1) (18.3–23.8) 0.69 (0.59–0.81) 0.82 (0.71–0.93)
 Medium metro 9,423 (23.3) (19.1–27.5) 5,828 (22.6) (18.2–27.0) 220,258 (24.0) (20.7–27.2) 0.94 (0.81–1.10) 0.92 (0.80–1.06)
 Small metro 4,107 (10.2) (7.7–12.6) 2,723 (10.6) (7.8–13.3) 89,274 (9.7) (7.7–11.7) 1.09 (0.89–1.33) 1.06 (0.871.29)
 Micropolitan (nonmetro) 4,597 (11.4) (9.7–13.1) 2,860 (11.1) (9.4–12.8) 90,408 (9.8) (8.8–10.9) 1.13 (0.98–1.30) 1.16 (1.01–1.33)
 Noncore (nonmetro) 2,912 (7.2) (6.2–8.3) 1,810 (7.0) (5.9–8.1) 53,101 (5.8) (5.2–6.4) 1.22 (1.05–1.42) 1.28 (1.12–1.48)
Overdose intentg
 Unintentional 31,730 (74.8) (72.5–77.0) 21,683 (79.6) (77.3–81.9) 594,259 (63.9) (62.5–65.5) 1.24 (1.20–1.29) 1.20 (1.16–1.25)
 Intentional self-harm 7,540 (17.8) (16.0–19.5) 3,340 (12.3) (10.8–13.8) 295,761 (31.8) (30.4–33.3) 0.39 (0.34–0.44) 0.45 (0.40–0.50)
 Assault 152 (0.4) (0.2–0.5) 119 (0.4) (0.3–0.6) 2,018 (0.2) (0.19–0.24) 2.02 (1.31–3.11) 2.16 (1.40–3.34)
 Undetermined 3,005 (7.1) (5.9–8.3) 2,084 (7.7) (6.3–9.0) 37,003 (4.0) (3.6–4.3) 1.92 (1.64–2.25) 1.84 (1.58–2.16)
Admission to hospital
 Yes 23,328 (55.0) (41.0–49.1) 13,306 (48.9) (43.8–53.9) 335,867 (36.2) (35.0–37.3) 1.35 (1.22–1.50) d
 No 19,100 (45.0) (50.9–59.0) 13,920 (51.1) (46.1–56.2) 593,174 (63.8) (62.7–65.0) 0.80 (0.73–0.88) d
Diedh
 Yes 673 (1.6) (1.3–1.9) 336 (1.2) (0.9–1.5) 7,574 (0.8) (0.77–0.87) 1.51 (1.16–1.96) 0.91 (0.71–1.16)
 No 41,621 (98.4) (98.1–98.7) 26,813 (98.8) (98.5–99.1) 917,967 (99.2) (99.1–99.2) 1.00 (0.99–1.00) 1.00 (1.00–1.00)
Cardiovascular effectsi
 Yes 10,157 (23.9) (22.7–25.2) 7,056 (25.9) (24.4–27.5) 126,567 (13.6) (13.1–14.1) 1.90 (1.79–2.03) 1.69 (1.59–1.80)
 No 32,271 (76.1) (74.8–77.3) 20,170 (74.1) (72.5–75.6) 802,473 (86.4) (85.9–86.9) 0.86 (0.84–0.88) 0.89 (0.87–0.91)
Central nervous system (seizure) effectsj
 Yes 1,510 (3.6) (3.1–4.0) 872 (3.2) (2.7–3.7) 31,105 (3.3) (3.2–3.5) 0.96 (0.82–1.11) 0.80 (0.69–0.93)
 No 40,910 (96.4) (96.0–96.9) 26,354 (96.8) (96.3–97.3) 897,935 (96.7) (96.5–96.8) 1.00 (1.00–1.01) 1.01 (1.00–1.01)

Source: Nationwide Emergency Department Sample

a

International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) included T43.621A, T43.621D, T43.621S, T43.622A, T43.622D, T43.622S, T43.623A, T43.623D, T43.623S, T43.624A, T43.624D, T43.624S.

b

International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) included T36-T50 diagnosis codes for all encounters (i.e., initial, subsequent, and sequelae) excluding adverse effects and underdosing and excluding amphetamine-type stimulant overdose codes (i.e., T43.621A, T43.621D, T43.621S, T43.622A, T43.622D, T43.622S, T43.623A, T43.623D, T43.623S, T43.624A, T43.624D, T43.624S).

c

Referent group for prevalence ratios is drug overdose not including amphetamine-type stimulants. Separate bivariable (Unadjusted PR) and multivariable (Adjusted PR) logistic regression models were developed to examine the relationship between each covariable (row) and only ATS-involved overdose compared to overdoses not involving ATS. Predicted marginals from logistic regression models were used to calculate prevalence ratios.

d

Only bivariable models for sex, age, and admission to the hospital are presented because no covariates remained in adjusted models after model reduction.

e

Adjusted for county urbanization level.

f

Determined based on NCHS 2013 Urban-Rural classification scheme (https://www.cdc.gov/nchs/data/series/sr_02/sr02_166.pdf); Adjusted for census region.

g

Intent is determined based on 5th or 6th character is the ICD–10–CM drug poisoning code; Adjusted for sex.

h

Adjusted for intent and admission to hospital.

i

International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) included I15.8, I15.9, I16, I20, I21, I24.8, I24.9, I46, I47, I48, I49, I60, I61, I62, I63, I71, I72, R00, R03.0; Adjusted for admission to hospital.

j

International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) included G40; Adjusted for age.